H
emorrhage from extremity injuries has been recognized in wars throughout history as the leading cause of potentially preventable death on the battlefield. Bellamy's landmark article on causes of death on the battlefield during the Vietnam War identified that 9% of potentially preventable battlefield deaths were from extremity hemorrhage. 1 Military surgeons from Operation Restore Hope in Somalia in 1993 similarly recognized a significant portion of hemorrhagic deaths from compressible hemorrhage. 2, 3 Autopsy data from the current conflict confirms the previous findings. 4 These data and experiences have focused US military surgical research on the treatment of extremity and compressible hemorrhage for the decade leading up to Operations Enduring and Iraqi Freedom. Control of extremity hemorrhage has been identified as the top priority for prehospital combat casualty care providers. 5, 6 For the first time since the Vietnam War, US military casualties are occurring in numbers allowing the study of the prehospital treatment of life-threatening extremity hemorrhage. Although considerable evidence exists implicating extremity hemorrhage as a significant cause of potentially preventable death on the battlefield, relatively few clinical series specifically analyzing the effectiveness of tourniquets on hemorrhage control and casualty outcome have been published. In his article on tourniquet problems in war injuries from World War II, Wolff and Adkins concluded that properly applied extremity tourniquets reduced blood loss, were associated with low risk of complications, and saved lives. 7 In the most modern series to date of prehospital tourniquet use from the Israeli Defense Force's experience, Lakstein et al. demonstrated that the combination of aggressive tourniquet use training and guidelines with a rapid evacuation and trauma care system can prevent deaths from extremity hemorrhage with an acceptably low tourniquet-related complication rate. 8 At the time of the initiation of the data collection for this study (July 2004) , standardized tourniquets were just starting to be deployed into Afghanistan and Iraq, but a liberalized policy of tourniquet use-using a tourniquet as a first-line treatment for extremity hemorrhage in casualties under firealthough standard in the special operations arena, had not been widely disseminated through conventional forces. The purpose of this investigation was to analyze the employment of tourniquets at a single combat support hospital (CSH) in Iraq and determine the effect of tourniquets on extremity hemorrhage control and outcomes. We hypothesized that prehospital tourniquet use decreased hemorrhage from extremity injuries and saved lives, and was not associated with an increase in adverse limb outcomes (e.g., secondary amputation or neurologic deficits).
PATIENTS AND METHODS
A retrospective analysis was performed under Brooke Army Medical Center institutional review board-approved protocol #I.2005.178d. The analysis included all patients in whom a prehospital extremity tourniquet was used, all patients with traumatic extremity amputations (excluding partial amputations of foot, hand, or digits), and all patients with extremity vascular injuries (named vessel) who arrived at the 31st CSH between January 1 and December 31, 2004. Patients whose severe trunk or head injuries were thought to be the primary injury affecting outcome were excluded. The following data points were collected: age, sex, nationality, mechanism of injury, location of injury, documented extremity injury, associated injuries, presence of tourniquet, tourniquet time (minutes), operation performed (vascular reconstruction, vascular ligation without amputation, primary or debridement amputation), Injury Severity Score (ISS), Acute Injury Score for the Extremity, arrival physiologic parameters (heart rate [HR], systolic blood pressure [SBP] , diastolic blood pressure, temperature, base deficit, pH, and hematocrit), blood products required (packed red blood cells, fresh whole blood, fresh frozen plasma, cryoprecipitate, rFVIIa), disposition (death, return to duty or discharge, evacuation), and length of stay (days). Assessment of extremity hemorrhage on arrival, scored simply as "active bleeding" or "no bleeding," was gained by review of patients' history and physical performed by the admitting surgeon or in some instances by direct interview with the surgeon involved. The primary outcomes measured were death, secondary amputation, and tourniquet-related complications. Follow-up data including additional procedures, complications, and outcomes on US soldiers evacuated out of theater were obtained via the Joint Theater Trauma Registry.
Patients with tourniquets were compared with those patients without tourniquets, first as a whole, then by matching patients for ISS Ͼ15, type of injury (patients requiring vascular reconstruction, patients requiring vascular ligations, patients requiring debridement amputations), and location of injury (forearm, arm, thigh, leg, multiple). Statistics were performed using SPSS Inc. version 11.0 software (SPSS Inc., Chicago, IL). Categorical data were compared using 2 analysis, with Fisher's exact test where appropriate. Continuous variables were compared using Student's t test.
RESULTS
Records from 3,444 patients in the 31st CSH database were reviewed. One hundred seventy-three (5%) patients were identified who suffered traumatic extremity amputation, major extremity vascular injury, or who had a prehospital tourniquet placed. Eight of these patients were excluded because they suffered significant or lethal trunk or head injuries, which were deemed to be the primary source of their arrival physiology, blood product requirements, and outcomes. Of the remaining 165 patients, 67 (40%) arrived at initial surgical care with prehospital tourniquet(s) in place and 98 (60%) arrived without prehospital tourniquets. Basic demographic data, mechanisms of injury, and mortality are shown in Table  1 . Iraqi casualties, most of whom had received prehospital care from US military medics, were just as likely to get a tourniquet as US casualties.
A total of 80 tourniquets were placed on the 67 patients. Anatomic location of these tourniquets is shown in Figure 1 . Of the subset of patients with multiple extremity injuries, 15 (22%) of the patients in the tourniquet group had a total of 34 limbs injured. A total of 28 tourniquets were applied on these patients. Six injured limbs in this treated group did not have tourniquets placed on them, three (50%) of which had vascular injuries. Only one of these untreated limbs had active bleeding on arrival. Fifteen (15%) patients in the no tourniquet group had 33 total limbs injured ( p ϭ NS compared with the tourniquet group). There were two deaths in each multiple extremity injury subset. Although there were more amputations in the group of patients who had tourniquets applied and more patients who had limb salvage in the group without 
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tourniquets, these differences were not significant for this subset of patients. For those patients who arrived with tourniquets, 41 (61%) had prehospital tourniquet times documented. Of these, the average tourniquet time was 70 minutes (range, 5-210 minutes). Other prehospital data, such as field vital signs, documentation regarding presence or absence of active bleeding, and other interventions performed were usually absent or otherwise so limited that they were not included in the analysis.
Analysis of Hemorrhage Control (Tourniquet Effectiveness)
Information regarding the presence or absence of active bleeding at the time of initial surgical care was available for 42 (63%) of the 67 patients with prehospital tourniquets and 28 (28%) of the 98 patients who arrived without prehospital tourniquets. Eighty-six patients (35 tourniquet, 51 no tourniquet) with ISS Ͼ15 were identified. Of these, 20 (57%) patients with tourniquets and 24 (55%) patients without tourniquets had documentation regarding status of hemorrhage control on arrival. Table 2 displays this data for all patients together, for only the patients with injuries that required primary or debridement amputations (e.g., nonsalvageable limbs), for only patients that has reconstructable vascular injuries, for those patients with upper extremity injuries, for those patients with lower extremity injuries, and for patients with ISS Ͼ15.
Of the 42 patients for whom documentation regarding tourniquet effectiveness was available, a total of 52 tourniquets were placed. Eight (15%) of these 52 tourniquets were documented as ineffective at controlling hemorrhage on arrival. Of these, four were above-knee (thigh) tourniquets, two were below-knee (leg) tourniquets, and two were belowelbow (forearm) tourniquets. Twelve (18%) of the patients in the tourniquet group had no documented vascular injury or major traumatic amputation. Based on the injuries treated in this group of patients, these tourniquets were nonindicated. However, prehospital provider observations regarding the extent of active bleeding in the field and the tactical situation were not available. One (1.5%) of the tourniquets was documented as incorrectly placed (i.e., placed distal to the wound). This incorrectly placed tourniquet was on 1 of the 12 casualties that did not have a documented major vascular injury or traumatic amputation. One other patient was noted to have extensive QuikClot in the wound distal to the tourniquet. This patient also did not have a major vascular injury or traumatic amputation. This patient's limb was salvaged.
Eleven tourniquets (14%) in six patients were documented to have controlled active hemorrhage on the patient's arrival to the trauma bay, but bleeding was noted to resume once active resuscitation of the casualty began. All of the tourniquets in which this rebleeding phenomenon was noted were placed in an above-knee location.
Analysis of Tourniquet Use Based on the Type of Injuries Sustained
Numbers and percentages of patients with injuries requiring vascular reconstruction and primary or debridement amputation are listed for each group (tourniquet vs. no tourniquet) in Table 3 .
Distribution of limbs injured is shown in Table 4 . Significantly more patients with arm injuries arrived to the level of surgical care without a tourniquet than with a tourniquet ( p ϭ 0.02). Eighteen of 30 (58%) patients who arrived without arm tourniquets had brachial artery injuries which required reconstruction, and 8 (27%) of them had traumatic amputations. Mean arrival physiologic parameters for all patients are listed in Table 5 . Mean arrival physiologic parameters for patients with ISS Ͼ15 are shown in Table 6 . The only significant difference in these parameters between patients who arrived with prehospital tourniquets and those who arrived without tourniquets was the mean Acute Injury Score-extremity score in patients with ISS Ͼ15 was higher in the group with prehospital tourniquets placed.
Mean total blood product requirements (for the entire stay at 31st CSH) for all patients are listed in Table 7 . Mean total blood requirements for patients with ISS Ͼ15 are shown in Table 8 .
Mortality
Three of 67 (4.4%) patients with tourniquets versus 4 of 98 (4.1%) without tourniquets died ( p ϭ NS). Descriptions of these cases follow:
Deaths in Casualties With Tourniquets Patient 1. A 37-year-old man sustained bilateral upper extremity burns, near amputation of right lower extremity just below level of groin, and a left calf crush injury from an improvised explosive device. He had a tourniquet placed in the right groin, but no comments on effectiveness of tourniquet were available. The patient arrived undergoing CPR and was declared dead in the ER shortly thereafter. Patient 2. A 28-year-old man sustained bilateral mangled lower extremities from proximal thighs to feet, traumatic right trans-humeral amputation, and fragment injury to left brachial artery with active bleeding and a pulseless limb from an improvised explosive device. Prehospital tourniquets had been applied to both groins and the right arm and no bleeding was noted from these injuries on arrival. No tourniquet had been placed proximal to left arm arterial injury. Once resuscitation began (in the operating room [OR]), the right arm tourniquet was noted to maintain hemorrhage control but some bleeding resumed through the thigh tourniquets, which 
Follow-up and Analysis of Tourniquet-Related Complications
Follow-up data were available for 52% of US casualties. No late deaths were noted. Average follow-up was 47 days for US casualties and 10 days for non-US casualties. Secondary amputations (after initial limb salvage) at the CSH or after evacuation from the CSH were required for a total of 13 patients; 4 (6%) in the group who received prehospital tourniquets and 9 (9%) in the group that did not ( p ϭ NS). There were no identified complications related specifically to tourniquet use, and no late neurologic injuries that could be clearly related to a tourniquet use were documented.
DISCUSSION

Analysis of Special Operations Forces casualties killed in action during the Global War on Terrorism (2001-2004
) revealed that 13% of those casualties who had potentially survivable injuries died of hemorrhage amenable to a tourniquet. 4 In a separate, unpublished analysis of 35 casualties who died of only isolated extremity injuries early (2001) (2002) (2003) (2004) in the Global War on Terrorism, 18 (51%) of these deaths were potentially preventable with the use of an extremity tourniquet. It should be noted that the tactical situations and medical capabilities at the scenes of these casualties is unknown (John Holcomb, MD, June 2007, personal communication).
Although our data did not show a survival benefit for prehospital tourniquet use, it is biased toward those patients that survived evacuation off the battlefield to the CSH. We were unable to obtain data on casualties that died before reaching surgical care during the study time period. Our data demonstrate that the use of a tourniquet is associated with improved hemorrhage control for severely injured patients sustaining major extremity vascular injuries or traumatic amputations. Furthermore, we encountered no significant adverse sequelae related to prehospital tourniquet use. The absence of neurologic complications in our dataset may be related to the relatively short prehospital tourniquet times documented (mean, 70 minutes).
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This data coincides well with previously published reports. 7, 8 To date, the most detailed case series analyzing tourniquet use on the battlefield is Lakstein et al.'s article documenting the experience of the Israeli Defense Force Medical Corps. 8 These researchers reviewed 550 cases of soldiers treated in the prehospital setting, 91 of whom were treated with a tourniquet. They documented a high rate of nonindicated tourniquets (47%), indicating liberal guidelines for tourniquet use. Notably, no deaths from extremity hemorrhage and a low neurologic complication rate (5.5%) were documented in their series. The few neurologic complications were all in casualties whose tourniquet times were 109 minutes to 187 minutes. Our nonindicated tourniquet rate of 18% reflects a comparatively conservative employment of prehospital extremity tourniquets in the early part of the war. Ongoing analysis is expected to show that the nonindicated tourniquet rate has risen since deployment of individual tourniquets to each soldier and dissemination of doctrine liberalizing their use.
In Wolff and Adkins's analysis of "200 random cases" of tourniquet use during the Italian campaign (1941) (1942) (1943) , no tourniquet-related complications were noted for a 5-to 10-day observation period after a tourniquet application between 2 hours and 4 hours. However, little clinical data aside from illustrative case reports were presented. 7 In their article, Wolff and Adkins also recognized short-comings in training, application, and management of tourniquets by both prehospital and hospital personnel and made recommendations regarding the management of tourniquets, including the dictum that tourniquets not be removed or intermittently loosened before arrival to surgical care. Wolff and Adkins's conclusions and recommendations for tourniquet management were authoritative (and still relevant today) by virtue of the experiences documented, which included treatment of over 1,000 amputation patients by his auxiliary surgical group.
Despite these aforementioned published clinical data compiled by military researchers and the anecdotal experience of military surgeons supporting prehospital tourniquet effectiveness, prehospital tourniquet use remained controversial for many years.
9,10 Employment of tourniquets by civilian prehospital services was abandoned over largely unfounded concerns of unacceptably high rates of limb loss or neurologic injuries related to tourniquet use. In addition, the concern that improperly applied tourniquets would increase hemorrhage from nonamputated limbs with vascular injuries by creating a venous tourniquet effect contributed to this reluctance to use prehospital tourniquets in civilian emergency settings. This condemnation of tourniquets as instruments, which cause more harm than good is somewhat difficult to understand in light of considerable clinical evidence demonstrating tourniquet safety when used appropriately in elective operative settings.
11
A final reason for not employing standard prehospital tourniquets in civilian trauma settings may stem from the perception that exsanguinating extremity hemorrhage from civilian trauma mechanisms is relatively uncommon, prehospital times are short, and direct pressure or an improvised tourniquet can be applied in the rare instances when uncontrolled extremity bleeding is present. Indeed, a recent study by Dorlac et al. revealed that there are relatively low numbers of civilian deaths from extremity hemorrhage; however, in 57% of the cases analyzed, the hemorrhage site would have been amenable to control with a tourniquet. 12 Based on Dorlac et al.'s study, the Israeli Defense Forces study, and recent experiences from Operations Enduring and Iraqi Freedom, some civilian EMS services are beginning to carry extremity tourniquets on ambulances.
This historical reluctance to use tourniquets for control of extremity hemorrhage was still present in military prehospital providers early in Operation Iraqi Freedom and at the time of this study. Our data shows that patients with major vascular injuries and patients with arm injuries were less likely to have a prehospital tourniquet placed. The underutilization of tourniquets in these subsets of patients may be related to lack of clinical signs of hemorrhage (for example, a patient with a major vascular injury but a contained hematoma), ability to obtain hemorrhage control with other means (e.g., pressure dressing on an arm injury), or reluctance in the prehospital provider to place a tourniquet on an upper extremity for fear of ischemia and resultant limb loss. This has implications for medic training, particularly given our finding that patients with injuries amenable to vascular reconstruction were less likely to have a tourniquet applied. Anecdotal reports of soldiers dying from isolated vascular injuries amenable to a tourniquet have been published in national media outlets. 13 Research evaluating possible battlefield tourniquet systems began before the Global War on Terrorism. Calkins et al., through surveys and device testing by Special Operations corpsmen, established 15 specific criteria regarding the effectiveness, simplicity, ruggedness, and portability of battlefield tourniquet systems. 14 Walters et al. at the United States Army Institute of Surgical Research (USAISR) performed a systematic evaluation of the effectiveness of commercially available prehospital tourniquets in human volunteers, 15 with the goal of identifying a standard tourniquet to provided to soldiers and medics on the battlefield. This study identified three products that were able to reliably occlude arterial blood flow (as measured by Doppler signal) in 100% of volunteers. Two of these products, the Special Operations Forces Tactical Tourniquet (Tactical Medical Solutions, LLC) and the Combat Application Tourniquet-1 (North American Rescue Products, Inc.), both light-weight, compact, modular versions of the Spanish windlass tourniquet, have been deployed to combat zones as individually issued hemorrhage control devices. Each soldier carries his or her own tourniquet, and unit medics are supplied with additional numbers of these devices in their aid bags. Over 400,000 of these devices were deployed into combat theaters at the time of this writing (John B. Holcomb, MD, personal communication). The USAISR has recommended that a third tourniquet, the Emergency and Military Tourniquet (EMT, Delfi Innovations, Inc.) be deployed for placement in evacuation vehicles, battalion aid stations, and emergency departments.
Based on the data presented herein, the US Army Surgeon General published an All Army message in March 2005, recommending that all soldiers carry tourniquets.
Current military doctrine dictates the use of a tourniquet as first line treatment for all "life-threatening" extremity hemorrhage during the first stage of Tactical Combat Casualty Care, that portion of care that occurs although the casualty is under active fire. Only when the casualty has been evacuated from active direct or indirect fire may the tourniquet be reassessed. First, a pressure or hemostatic dressing is applied to the wound and the casualty is resuscitated if needed. Hemodynamically unstable casualties or casualties with decreased mental status should not have the tourniquet loosened in the field. Stable and mentating casualties with injuries that appear less severe may have the tourniquet loosened with a period of direct observation. If bleeding resumes, the tourniquet should be tightened and the patient evacuated. The tourniquet should only be loosened by a medical officer in this case. If the hemorrhage control can be maintained with another method (e.g., pressure dressing), the tourniquet can remain loosened but should be frequently monitored. If this monitoring is not possible, continued use of the tourniquet should be preferred over the risk of unnoticed rebleeding. 16 The observed result of this doctrinal change is that most casualties with extremity injuries are now arriving to the level of surgical care with a tourniquet in place (Matthew J. 
Limitations
Several limitations to this dataset are apparent, many of which are common to combat casualty care research projects. The data are retrospective and from a single hospital. There is very little prehospital data; for example, almost 40% of casualties who had prehospital tourniquets applied do not have tourniquet times documented. There is essentially no data available regarding the tactical environment in which the tourniquet was applied. Such factors as delays in casualties receiving first responder care and delays in evacuation related to ongoing combat or tactical needs will affect outcome in some patients. Interviews with first responders to obtain data regarding the appearance of the casualties' wounds and the presence or absence of arterial or venous bleeding were not possible primarily because of the operation tempo of both the combat units and the CSH. Times from injury to arrival at hospital were not available, and data from echelon 1 (battalion aid stations) and echelon 2b facilities (forward surgical teams) was frequently incomplete or absent.
Data on the presence or absence of bleeding is only available in 28% of the patients that did not receive prehospital tourniquets. This may have been because of the tempo of operations, or possibly surgeons were less likely to document a negative finding compared with a positive finding. Hence, many of the patients in the group that did not receive tourniquets may not have had bleeding on arrival, and this could introduce a bias in the analysis of the effectiveness of tourniquets on hemorrhage control. It should in fact be noted that the group of patients that had tourniquets applied and the ones that did not are indeed different groups. More patients that required debridement amputations were found in the tourniquet group, and more patients that had injuries amenable to vascular reconstruction were seen in the group without tourniquets. This difference is likely related to the physical findings that would prompt a medic to place a tourniquet. Patients who required primary or debridement amputations frequently had dramatic appearing traumatic amputations (Fig. 2) , mangled extremities (Fig. 3) , or severe soft tissue components to their wounds (Fig. 4) . Patients with reconstructable vascular injuries were more likely to have less soft tissue and bony destruction and contained hematoma without active bleeding (Fig. 5) . Hence, medics were less likely to place a tourniquet on these injuries. Dr. Alec C. Beekley (Department of General Surgery, Madigan Army Medical Center, Fort Lewis, WA): I thank Dr. Ficke for his balanced and constructive review of our article from the perspective of an orthopedic surgeon with extensive experience in both civilian and military extremity trauma. His comments serve to highlight the strengths and weaknesses of our data and will assist in directing future research on prehospital tourniquet use in both military and civilian settings.
Some of the challenges to performing a retrospective chart review to analyze a prehospital intervention in a busy combat support hospital were noted by Dr. Ficke. Specifically, he noted that data on tourniquet effectiveness or the presence or absence of hemorrhage on arrival was only available on just over half of the casualties. Surgeons' notes on critically injured casualties were often by necessity brief and to the point (e.g., "History: Soldier with blast injuries to all extremities; unstable; tourniquets applied; Plan: to OR."). This emphasizes the need for prospective data collection, ideally by personnel not directly involved in the patient's care. The Deployed Combat Casualty Research Team has performed just such data collection on tourniquet use in the last 12 months. Research personnel were at the bedside in the trauma bay on each casualty that arrived with a prehospital tourniquet to document valuable data regarding injuries, tourniquet location, type and number of tourniquets used, effectiveness, times, physiologic data, and to photograph the injured limb(s). Over 700 patients and close to 1,000 tourniquet applications have been recorded in this fashion. Analysis of this data will undoubtedly answer many of the questions our data was unable to answer.
Dr. Ficke also noted that follow-up data was only available on 52% of patients, and we agree that it is difficult to draw definitive conclusions regarding tourniquet complications because of this. The imperfect data we do have, combined with our own observations, allows us to form opinions on the safety and complication profile of prehospital tourniquets, but we agree with the reviewer that it is important to state them as such.
Finally, in response to Dr. Ficke's comments on the use of pneumatic tourniquets to replace prehospital tourniquets, I agree with the concept that augmentation of a prehospital tourniquet may be a better strategy where feasible. Our study group found that the prehospital tourniquets most likely to provide inadequate hemorrhage control during resuscitation were in the proximal thigh location, and we frequently found that there was simply no room on the extremity between the wound and the prehospital tourniquet or between the prehospital tourniquet and the torso to add an additional pneumatic tourniquet for augmentation. Using a two-person technique, we found we were able to replace inadequate field tourniquets with robust, wide operating room pneumatic tourniquets in a rapid fashion with little additional blood loss. The broader take-home lesson from this discussion is that prehospital tourniquets must be checked for adequacy on arrival of the casualty and rechecked frequently during resuscitation to avoid unnecessary continued blood loss. The few minutes spent on augmentation or replacement of an inadequate prehospital tourniquet will be minutes well spent.
